Patents by Inventor Stefan Gilch

Stefan Gilch has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20180142266
    Abstract: There is provided a microbial cell which is capable of producing at least one higher alcohol, wherein the microbial cell is genetically modified to include an increased expression relative to its wild type cell of at least one acyl-CoA reductase (E11). In particular, there is provided a microbial cell capable of producing at least one higher alcohol, wherein the microbial cell is genetically modified to include an increased expression relative to its wild type cell of at least one acyl-CoA reductase (E11) and wherein the cell is capable of producing a carboxylic acid and/or ester thereof using ethanol-carboxylate fermentation.
    Type: Application
    Filed: June 10, 2016
    Publication date: May 24, 2018
    Inventors: Thomas Haas, Anja Hecker, Stefan Gilch, Thomas Bülter
  • Patent number: 9885060
    Abstract: The present invention provides a microbial cell capable of producing at least one terminal alkene from at least one short chain fatty acid, wherein the cell is genetically modified to comprise at least a first genetic mutation that increases the expression relative to the wild type cell of an enzyme (E1) selected from the CYP152 peroxygenase family, and at least a second genetic mutation that increases the expression relative to the wild type cell of at least one NAD(P)+ oxidoreductase (E2) and the corresponding mediator protein, wherein the short chain fatty acid is a C4-C10 fatty acid.
    Type: Grant
    Filed: February 25, 2016
    Date of Patent: February 6, 2018
    Assignee: Evonik Degussa GmbH
    Inventors: Alexander Dennig, Kurt Faber, Melanie Hall, Thomas Haas, Thomas Buelter, Stefan Gilch, Anja Thiessenhusen
  • Publication number: 20160326549
    Abstract: The present invention provides a microbial cell capable of producing at least one terminal alkene from at least one short chain fatty acid, wherein the cell is genetically modified to comprise at least a first genetic mutation that increases the expression relative to the wild type cell of an enzyme (E1) selected from the CYP152 peroxygenase family, and at least a second genetic mutation that increases the expression relative to the wild type cell of at least one NAD(P)+ oxidoreductase (E2) and the corresponding mediator protein, wherein the short chain fatty acid is a C4-C10 fatty acid.
    Type: Application
    Filed: February 25, 2016
    Publication date: November 10, 2016
    Applicant: Evonik Degussa GmbH
    Inventors: Alexander DENNIG, Kurt FABER, Melanie Hall, Thomas Haas, Thomas Buelter, Stefan Gilch, Anja Thiessenhusen